List of Exagen Diagnostics patents

List of Exagen Diagnostics patents

List of Organogenesis patents

List of University of Guanajuato patents

List of Coupa Software patents

List of funding rounds for Omada Health

List of companies in Accel-KKR's investment portfolio

Patents where

Current Assignee

Name

is

Exagen Diagnostics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7698071 Methods and devices relating to estimating classifier performance	Patent 7698071 was granted and assigned to Exagen Diagnostics on April, 2010 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7698071	April 13, 2010
	‌ US Patent 7561971 Methods and devices relating to estimating classifier performance	Patent 7561971 was granted and assigned to Exagen Diagnostics on July, 2009 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7561971	July 14, 2009
	‌ US Patent 7534875 Compositions for glioma classification	Patent 7534875 was granted and assigned to Exagen Diagnostics on May, 2009 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7534875	May 19, 2009
	‌ US Patent 7923544 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 7923544 was granted and assigned to Exagen Diagnostics on April, 2011 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7923544	April 12, 2011
	‌ US Patent 7557198 Acute myelogenous leukemia biomarkers	Patent 7557198 was granted and assigned to Exagen Diagnostics on July, 2009 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7557198	July 7, 2009
	‌ US Patent 7879553 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 7879553 was granted and assigned to Exagen Diagnostics on February, 2011 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7879553	February 1, 2011
	‌ US Patent 7833721 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 7833721 was granted and assigned to Exagen Diagnostics on November, 2010 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7833721	November 16, 2010
	‌ US Patent 8073630 Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis	Patent 8073630 was granted and assigned to Exagen Diagnostics on December, 2011 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	8073630	December 6, 2011
	‌ US Patent 8227589 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 8227589 was granted and assigned to Exagen Diagnostics on July, 2012 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	8227589	July 24, 2012
	‌ US Patent 7833720 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 7833720 was granted and assigned to Exagen Diagnostics on November, 2010 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	7833720	November 16, 2010
	‌ US Patent 8222390 Biomarkers for inflammatory bowel disease and irritable bowel syndrome	Patent 8222390 was granted and assigned to Exagen Diagnostics on July, 2012 by the United States Patent and Trademark Office.		Exagen Diagnostics		United States Patent and Trademark Office	8222390	July 17, 2012

11 results

0 selected

11 results

0 selected